EDITORIAL
Published on 21 Apr 2020
Editorial: IBD Management—Novel Targets and Therapeutic Perspectives
doi 10.3389/fphar.2020.00448
- 2,410 views
- 3 citations
- Frontiers in Pharmacology
- Gastrointestinal and Hepatic Pharmacology
- Research Topics
- IBD Management - Novel Targets and Therapeutic Perspectives
IBD Management - Novel Targets and Therapeutic Perspectives
32k
Total downloads
203k
Total views and downloads
Articles
REVIEW
Published on 18 Jun 2019
Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor
doi 10.3389/fphar.2019.00671
- 8,088 views
- 65 citations
REVIEW
Published on 24 Apr 2019
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
doi 10.3389/fphar.2019.00314
- 6,803 views
- 31 citations
MINI REVIEW
Published on 29 Mar 2019
Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
doi 10.3389/fphar.2019.00305
- 103,757 views
- 105 citations
SYSTEMATIC REVIEW
Published on 19 Mar 2019
Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies
doi 10.3389/fphar.2019.00247
- 9,213 views
- 16 citations
REVIEW
Published on 13 Mar 2019
Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists
doi 10.3389/fphar.2019.00212
- 18,775 views
- 112 citations
MINI REVIEW
Published on 08 Feb 2019
Hsp60 as a Novel Target in IBD Management: A Prospect
doi 10.3389/fphar.2019.00026
- 5,314 views
- 29 citations
ORIGINAL RESEARCH
Published on 01 Feb 2019
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease
doi 10.3389/fphar.2019.00039
- 7,707 views
- 33 citations
REVIEW
Published on 10 Jan 2019
Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease – An Overview of Human Studies
doi 10.3389/fphar.2018.01571
- 15,241 views
- 109 citations
ORIGINAL RESEARCH
Published on 03 Dec 2018
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation
doi 10.3389/fphar.2018.01405
- 4,093 views
- 42 citations
ORIGINAL RESEARCH
Published on 31 Oct 2018
Qingchang Suppository Ameliorates Colonic Vascular Permeability in Dextran-Sulfate-Sodium-Induced Colitis
doi 10.3389/fphar.2018.01235
- 4,221 views
- 28 citations
REVIEW
Published on 08 Oct 2018
Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring
doi 10.3389/fphar.2018.01107
- 11,380 views
- 51 citations
